ArticleInternational health2026
Combining non-structural protein 1 and IgM tests for acute dengue diagnosis in Saudi Arabia.
Article in International health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundDengue is endemic in Saudi Arabia, particularly in Jeddah, Makkah and Jizan. Outbreaks in these regions are mainly linked to climate conditions and mass travel during religious pilgrimages.
methodsThis retrospective cross-sectional study evaluated the diagnostic performance of the non-structural protein 1 (NS1) antigen test and IgM ELISA, compared with RT-PCR. A total of 2850 samples were collected from patients hospitalised with moderate to severe symptoms across six regions in Saudi Arabia from 2022 to 2024. The samples were tested simultaneously using all three methods and 95% CIs were calculated using the Wilson score method.
resultsOut of 3419 samples analysed, 1402 tested negative for dengue and 1448 tested positive. The sensitivity of the NS1 antigen test was 73.5% (95% CI 70.7 to 76.2%). The IgM ELISA test demonstrated a sensitivity of 65.8% (95% CI 62.9 to 68.7%). Combining the results of both tests increased the sensitivity to 92.4% (95% CI 90.6 to 93.9%). This combined diagnostic approach facilitates the detection of both early-phase (NS1-positive) and later-phase (IgM-positive) infections, offering a more comprehensive diagnostic tool.
conclusionsImplementing a combined testing strategy within Saudi Arabia's diagnostic pipelines could enhance disease surveillance, enable earlier detection and strengthen public health efforts against dengue outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.